Inside a Campaign to Get Medicare Coverage for a New Alzheimer's Drug

The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.

Related Keywords

New York ,United States ,American ,Susan Collins ,Shelley Moore Capito ,Harry Johns ,Robert Egge ,Frank Pallone ,Maria Carrillo ,Carolynb Maloney ,Martha Stewart ,Daniel Gibbs ,Christopher Masak ,Beth Mcmullen ,Kate Johnson ,Beth Lynk ,Centers For Medicare ,New York Times ,American Academy Of Neurology ,Alzheimer Association ,Alzheimer Impact Movement ,Medicaid Services ,President Biden ,Impact Movement ,Jennifer Pollack ,American Academy ,Senator Susan Collins ,Senator Shelley Moore Capito ,Representatives Carolyn ,Your Feed Science ,Alzheimer X27 S ,Aduhelm ,Pharmaceuticals Prescription Drugs ,Old Age Elderly Senior Citizens ,Health Insurance ,Medicare ,Antibody ,Alzheimer X27s Assn ,Biogen ,Centers For Medicare And Medicaid Services ,Us ,Your Feed Healthcare ,